September 17th 2025, 7:00pm
By Alex Biese
For patients with advanced GIST Gleevec, complete surgical removal of metastasis and complete Gleevec response are associated with survival time doubling.
September 17th 2025, 5:00pm
By Laura Yeager
Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.
September 17th 2025, 4:00pm
By Ryan Scott
Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.
September 17th 2025, 3:10pm
By Spencer Feldman
The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.
September 17th 2025, 1:00pm
By Dr. Prithviraj Bose
Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.
September 16th 2025, 9:00pm
By Tamron Little
The first day of fall comes on September 22, and every year it feels like a reminder to pause.
September 16th 2025, 8:00pm
By Dr. Joshua K. Sabari
Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.
September 16th 2025, 7:00pm
Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.
September 16th 2025, 5:00pm
By Bonnie Annis
Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.
September 16th 2025, 4:00pm
For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received long-term treatment with Jakafi.
September 16th 2025, 3:00pm
The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.
September 16th 2025, 1:00pm
By Dr. Rosario Ligresti
Dr. Rosario Ligresti explained that while many GISTs are found incidentally, larger tumors may cause anemia, bleeding or swallowing issues.
September 15th 2025, 9:00pm
By Carla Deschamps
Five years after being diagnosed with colon cancer, I would like to share how my support system continues to play a role in my life after active treatment.
September 15th 2025, 8:00pm
By Dr. Geoffrey Liu
Dr. Geoffrey Liu discussed findings from the phase 2 TRUST-II clinical trial evaluating Ibtrozi (taletrectinib) among patients with ROS1-positive non-small cell lung cancer.
September 15th 2025, 7:00pm
Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.
Gleevec Associated With Long-Term Effectiveness in Treating GIST
The Days of a Breast Cancer Survivor
Prostate Cancer Survivor Encourages Men to Speak Up and Get Tested
Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia